Investors Encouraged to Lead PepGen Inc. Securities Fraud Class Action with Schall Law Firm

Overview of PepGen Securities Fraud Lawsuit

The Schall Law Firm, a renowned national firm specializing in shareholder rights, has stepped forward to remind investors about the ongoing class action lawsuit against PepGen Inc. (NASDAQ: PEPG). The lawsuit stems from alleged violations of federal securities laws, specifically §§10(b) and 20(a) of the Securities Exchange Act of 1934, along with Rule 10b-5 as enacted by the U.S. Securities and Exchange Commission (SEC).

Context of the Lawsuit

Investors who purchased shares of PepGen between March 7, 2024, and March 3, 2025, are particularly encouraged to engage with the law firm prior to the approaching deadline of August 8, 2025. The primary contention of the case is that PepGen, through misleading statements, misrepresented the safety and efficacy of its drug candidate, PGN-EDO51. The allegations suggest that the drug was not only less effective than claimed but also posed significant safety risks to trial participants. Critics assert that the CONNECT2 study backing this drug was insufficient for FDA approval and raised genuine health concerns.

Implications for Investors

When the truth about PepGen’s drug was finally revealed, it led to substantial damages for investors, who relied on the company's statements when making their investment choices. Consequently, shareholders who experienced losses are being urged to join the lawsuit to seek appropriate compensation for their investments. The Schall Law Firm is available for consultations, offering interested parties an opportunity to discuss their rights and any potential actions they may wish to take.

Next Steps for Interested Investors

Investors who identify themselves as being part of the class should contact Brian Schall at the Schall Law Firm, located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. They can also reach out via phone at 310-301-3335 or visit the firm's website at www.schallfirm.com for further details. It’s important to remember that the class has yet to be certified; hence, until this process is completed, individuals will not be formally represented by an attorney.

Why Choose Schall Law Firm?

The Schall Law Firm prides itself on representing investors globally, defending their rights against securities fraud through class action lawsuits. Their expertise in navigating the complexities of securities law positions them well to manage cases like this one, ensuring that shareholders potentially harmed by misleading corporate statements have a chance to recover their losses.

Call to Action

If you are a PepGen investor who has suffered losses during the specified period, consider joining this class action lawsuit. Failing to act could result in remaining an absent class member, obscuring your chance of recovering your losses. It is crucial to understand your rights as an investor and take the proactive steps necessary to reclaim your investment.